Bicarbonate

Bicarbonate

SCHEMBL10758307

CC1CCc2cc(C(=O)C3CC3)ccc2NC1=O.O=C(O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SMYD3 Q9H7B4 2/20 0.38
▸ CRBN Q96SW2 2/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ GRM1 Q13255 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ PYGL P06737 1/20 0.36
▸ PYGM P11217 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10647393 0.84 KMO (0.45) SMYD3CRBNMEN1KMT2APYGL
Bicarbonate SCHEMBL10764464 0.81 SMYD3 (0.55) SMYD3CRBN
SCHEMBL29003174 0.80 SMYD3 (0.38) SMYD3CRBNMEN1KMT2APYGL
Bicarbonate SCHEMBL11126587 0.79 GSK3B (0.52) SMYD3CRBNKDM4EMAPT
Bicarbonate SCHEMBL11124451 0.77 SMYD3 (0.55) SMYD3
Bicarbonate SCHEMBL10765181 0.76 SMYD3 (0.53) SMYD3CRBN
SCHEMBL10760242 0.76 GSK3B (0.54) SMYD3CRBNGRM1KDM4EMAPT
SCHEMBL1347544 0.74 BRD4 (0.49) CRBNMEN1KMT2AMAPTPOLB
SCHEMBL5776045 0.74 SMYD3 (0.58) SMYD3
Bicarbonate SCHEMBL10760544 0.72 SMYD3 (0.53) SMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0220519-A2 Use of a 2-aryl-3,4-diaza-bicyclo[4.n.O]alk-2-en-5-one in the preparation of a medicament for the treatment of cardiac insufficiency BASF Aktiengesellschaft (DE) 1987-05-06 — — EP disclosed
Send feedback